Pure red cell aplasia

Pure Red Cell Aplasia

Red and white blood cells under a microscope.

Pure Red Cell Aplasia (PRCA) is a rare disorder characterized by a severe reduction in the production of red blood cells (RBCs) by the bone marrow. This condition results in anemia, which can lead to symptoms such as fatigue, pallor, and shortness of breath.

Pathophysiology

PRCA is primarily a disorder of the bone marrow, where the production of red blood cells is selectively inhibited. The bone marrow normally produces erythrocytes from hematopoietic stem cells through a process called erythropoiesis. In PRCA, this process is disrupted, leading to a marked decrease in the number of reticulocytes and mature red blood cells in the peripheral blood.

Causes

PRCA can be classified into congenital and acquired forms:

• Congenital PRCA: The most well-known form is Diamond-Blackfan anemia, a rare genetic disorder that presents in infancy or early childhood.

• Acquired PRCA: This form can be caused by various factors, including:

 * Autoimmune disorders such as systemic lupus erythematosus.
 * Viral infections, particularly parvovirus B19.
 * Thymoma, a tumor of the thymus gland.
 * Certain medications and chemotherapy agents.

Diagnosis

The diagnosis of PRCA involves a combination of clinical evaluation, laboratory tests, and bone marrow examination. Key diagnostic features include:

• Severe anemia with low reticulocyte count.
• Normal white blood cell and platelet counts.
• Bone marrow biopsy showing a marked reduction or absence of erythroid precursors.

Treatment

The treatment of PRCA depends on the underlying cause:

• For autoimmune PRCA, immunosuppressive therapy with drugs such as corticosteroids or cyclosporine may be effective.
• In cases associated with thymoma, surgical removal of the tumor can lead to improvement.
• For PRCA caused by parvovirus B19, intravenous immunoglobulin (IVIG) therapy may be used.

Prognosis

The prognosis of PRCA varies depending on the cause and response to treatment. Some patients may achieve complete remission, while others may require long-term management.

Related pages

• Anemia
• Bone marrow
• Erythropoiesis
• Hematopoietic stem cell